XML 49 R34.htm IDEA: XBRL DOCUMENT v3.3.1.900
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2015
Income Tax Disclosure [Abstract]  
Component of Consolidated Income (Loss) Before Provision for Income Taxes

Consolidated income (loss) before provision for income taxes consisted of the following (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

U.S.

 

$

(107,450

)

 

$

(91,121

)

 

$

(67,004

)

Non U.S.

 

 

656

 

 

 

399

 

 

 

284

 

Total

 

$

(106,794

)

 

$

(90,722

)

 

$

(66,720

)

 

Difference Between Consolidated Income Tax Benefit and Amount Computed by Federal Statutory Income Tax Rate

No income tax expense was recorded for the years ended December 31, 2015, 2014 and 2013 due to net operating loss carryforwards to offset the net income at Dynavax GmbH and a valuation allowance which offsets the deferred tax assets. The difference between the consolidated income tax benefit and the amount computed by applying the federal statutory income tax rate to the consolidated loss before income taxes was as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2015

 

 

2014

 

 

2013

 

Income tax benefit at federal statutory rate

 

$

(36,301

)

 

$

(30,818

)

 

$

(22,678

)

State tax

 

 

(394

)

 

 

1,204

 

 

 

(178

)

Business credits

 

 

(2,622

)

 

 

(1,484

)

 

 

(2,515

)

Deferred compensation charges

 

 

1,481

 

 

 

2,710

 

 

 

3,072

 

Change in valuation allowance

 

 

36,766

 

 

 

28,093

 

 

 

22,354

 

Other

 

 

1,070

 

 

 

295

 

 

 

(55

)

Total income tax expense

 

$

-

 

 

$

-

 

 

$

-

 

 

Component of Deferred Tax Assets and Liabilities

Deferred tax assets and liabilities consisted of the following (in thousands): 

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss carry forwards

 

$

212,074

 

 

$

178,008

 

Research tax credit carry forwards

 

 

26,285

 

 

 

22,914

 

Accruals and reserves

 

 

9,771

 

 

 

9,053

 

Capitalized research costs

 

 

6,553

 

 

 

8,601

 

Deferred revenue

 

 

908

 

 

 

654

 

Other

 

 

1,375

 

 

 

1,531

 

Total deferred tax assets

 

 

256,966

 

 

 

220,761

 

Less valuation allowance

 

 

(256,712

)

 

 

(220,544

)

Net deferred tax assets

 

 

254

 

 

 

217

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Fixed Assets

 

 

(254

)

 

 

(217

)

Total deferred tax liabilities

 

 

(254

)

 

 

(217

)

Net deferred tax assets

 

$

-

 

 

$

-

 

 

Schedule of Unrecognized Tax Benefits

The following table summarizes the activity related to the Company’s unrecognized tax benefits:

 

Balance at December 31, 2014

 

$

(2,426

)

Tax positions related to the current year

 

 

 

 

  Additions

 

 

-

 

  Reductions

 

 

-

 

Tax positions related to the prior year

 

 

 

 

  Additions

 

 

-

 

  Reductions

 

 

-

 

Balance at December 31, 2015

 

$

(2,426

)